Janux Therapeutics, Inc.JANXNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-96.79M
↓ 109% below average
Average (5y)
$-46.20M
Historical baseline
Range
High:$-3.77M
Low:$-96.79M
CAGR
+91.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-96.79M | -36.3% |
| 2023 | $-71.02M | -7.2% |
| 2022 | $-66.25M | -101.9% |
| 2021 | $-32.82M | -399.9% |
| 2020 | $-6.57M | -74.4% |
| 2019 | $-3.77M | - |